STAFF

> Hospital Authority Medical Staffback
A photo of Dr WANG Yee-Moon, Angela
Dr WANG Yee-Moon, Angela
Senior Medical Officer (Queen Mary Hospital)
Honorary Clinical Associate Professor
MB BS (Uni. N.S.W.), MD (Uni. N.S.W.), PhD (HKU), MRCP (UK), FRCP (Lond/Edin), FHKCP, FHKAM, FASN
an email logo aymwang@hku.hk
a telephone logo 2255-4949
a fax logo 2255-5411

Research Profile

  1. Cardiovascular disease and risk in chronic kidney disease and peritoneal dialysis
  2. Cardiac biomarkers research in chronic kidney disease
  3. Vascular calcification in chronic kidney disease
  4. Residual kidney function in peritoneal dialysis
  5. Nutrition in chronic kidney disease
  6. Mineral metabolism in chronic kidney disease and dialysis
  7. Clinical trials in chronic kidney disease and dialysis in the areas of cardiovascular disease, diabetes, hypertension, nutrition, vascular calcification and mineral metabolism

Selected Publications

  1. Wang AY, Brimble KS, Brunier G, Holt S, Jha V, Johnson DW, Kang SW, Kooman J, Lambie M, McIntyre C, Mehrotra R, Pecoits-Filho R. International Society of Peritoneal Dialysis Cardiovascular and Metabolic Guidelines in Adult Peritoneal Dialysis Patients Part I - Assessment and Management of Various Cardiovascular Risk Factors. Perit Dial Int 2015;35:379-387.
  2. Wang AY, Brimble KS, Brunier G, Holt S, Jha V, Johnson DW, Kang SW, Kooman J, Lambie M, McIntyre C, Mehrotra R, Pecoits-Filho R. International Society of Peritoneal Dialysis Cardiovascular and Metabolic Guidelines in Adult Peritoneal Dialysis Patients Part II - Management of Various Cardiovascular Complications. Perit Dial Int 2015;35:388-396.
  3. Wang AY, Wong CK, Yau YY, Wong S, Chan IH, Lam CW. Skin Autofluorescence associates with vascular calcification in chronic kidney disease. Arterioscler Thromb Vasc Biol 2014;34:1784-1790
  4. Cai QZ, Lu XZ, Lu Y, Wang AY. Longitudinal Changes of Cardiac Structure and Function in CKD (CASCADE Study). J Am Soc Nephrol 2014;25(7):1599-1608.
  5. Wang AY, Fang F, Chan J, Wen YY, Qing S, Chan IH, Lo G, Lai KN, Lo WK, Lam CWK, Yu CM. Oral paricalcitol treatment on left ventricular mass and function in stages 3 - 5 chronic kidney disease patients with cardiac hypertrophy (OPERA Study): a randomized controlled trial. J Am Soc Nephrol 2014;25:175-186
  6. Wang AY, Wang M, Lam CWK, Chan HIS, Lui SF, Sanderson JE. Heart failure with preserved or reduced ejection fraction in patients treated with peritoneal dialysis. Am J Kidney Dis 2013;61:975-983
  7. Jha V, Garcia-Garcia G, Iseki K, Li Z, Naicker S, Plattner B, Saran R, Wang AY, Yang CW. Chronic Kidney Disease: Global Dimension and Perspectives. The Lancet 2013;382:260-272
  8. Ikizler AT, Cano NJ, Franch HA, Fouque D, Himmelfarb J, Kalantar-Zadeh K, , Kuhlmann M, Stenvinkel P, TerWee P, Teta D, Wang AY, Wanner C. Prevention and Treatment of Protein Energy Wasting in Chronic Kidney Disease Patients: A joint statement from the International Society of Renal Nutrition and Metabolism. Kidney Int 2013;84:1096-1107
  9. Wang AY, Lam CW, Chan HS, Wang M, Lui SF, Sanderson JE. Sudden cardiac death in end-stage renal disease patients: A 5-year prospective analysis. Hypertension 2010;56:210-216
  10. Wang AY, Lai KN. The role of cardiac biomarkers in end-stage renal disease. J Am Soc Nephrol 2008;19;1643-1652
  11. Wang AY, Wang M, Lam CW, Chan IH, Sanderson JE. LV filling pressure by Doppler echocardiography in end-stage renal disease. Hypertension 2008;52:107-114
  12. Wang AY, Lai KN. The importance of residual renal function in dialysis patients. Kidney Int 2006;69:1726-1732
  13. Wang AY, Ho SS, Wang M, Liu EK, Ho S, Li PK, Lui SF, Sanderson JE. Is cardiac valvular calcification a marker of atherosclerosis and arterial calcification in end-stage renal disease patients? Arch Intern Med 2005;165:327-332
  14. Wang AY, Wang M, Woo J, Lam CK, Lui SF, Li PK, Sanderson JE. Inflammation, residual kidney function and cardiac hypertrophy are interrelated and combine adversely to enhance mortality and cardiovascular death risk of peritoneal dialysis patients. J Am Soc Nephrol 2004;15:2186-2194
  15. Wang AY, Wang M, Woo J, Lam CK, Li PK, Lui SF, Sanderson JE. Cardiac valve calcification as an important predictor for all-cause mortality and cardiovascular mortality in long-term peritoneal dialysis patients: a prospective study. J Am Soc Nephrol 2003;13:159-168

Awards

  1. United State National Kidney Foundation, Joel D. Kopple Award 2018
  2. Asian & Pacific Federation of Clinical Biochemistry Travelling Lecturer Award 2011 – 2012
  3. John Maher Award of the ISPD 2006
  4. Best Abstract Award, World Congress of Nephrology 2005
  5. Best Abstract Poster Award, ISPD/European Peritoneal Dialysis Meeting 2004
  6. Distinguished Abstract Award, ISPD First Asian Chapter Meeting 2002
  7. Young Investigator Award, International Society of Peritoneal Dialysis (ISPD) 2001

Key Offices

  1. President, International Society of Renal Nutrition and Metabolism (ISRNM) (June 2018 - )
  2. President-Elect, International Society of Renal Nutrition and Metabolism (ISRNM) (April 2016 – June 2018 )
  3. Executive Committee member, Kidney Disease Improving Global Outcomes (KDIGO) (2015 - 2017)
  4. North and East Asia Regional Board Member, International Society of Nephrology (2017 - )
  5. Committee member, International Society of Nephrology (ISN)-Advancing Clinical Trial Core Workgroup (June 2016 - )
  6. Executive Committee Member, Standardised Outcomes in Nephrology (SONG) Initiative (2017 - )
  7. Council member, International Society of Peritoneal Dialysis (ISPD) (Feb 2016 - )
  8. Core Workgroup member, SONG-HD CVD Outcome Measures Working Group (Sept 2016 –)
  9. Core Workgroup member, SONG-PD Outcome Measures Working Group (Dec 2016 –)
  10. Workgroup member, ISPD Dialysis Adequacy Guideline Update 2017 (July 2017 - )
  11. Secretary, ISRNM (2014 - 2016)
  12. Council member, ISRNM (2011-2014)
  13. Subcommittee Chair, Kidney Disease Outcome Quality Initiative (KDOQI) Nutrition Guidelines in Chronic Kidney Disease (2015 - )
  14. Board member, KDIGO (2011-2015)
  15. Chair, ISPD Adult Cardiovascular and Metabolic Guidelines (2012 - 2015, guideline published in July 2015 )
  16. Subcommittee Chair, ISPD Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS) (2012 -)
  17. Workgroup member, KDIGO Chronic Kidney Disease – Mineral Bone Disease (CKD-MBD) Clinical Practice Guidelines (2007-2009, guideline published in 2009)
  18. Board member, Faculty of 1000 Medicine, United Kingdom (2007 -)
  19. Committee Member, International Studies of ISPD (2006 – 2008) 

Editorial Board Memberships

  1. J Am Soc Nephrol (since 2007)
  2. Am J Kidney Dis (as Associate Editor 2009 - 2017)
  3. Clin J Am Soc Nephrol (2008 – 2013) as International Editor (2011-2013) and again (starting 2017 - )
  4. Nephrol Dial Transplant (Editor of Cardiovascular Risk section) (2017 - )
  5. Am J Nephrol (since 2009)
  6. J Nephrol (since 2008)
  7. J Renal Nutrition (since 2012)
  8. Nephron Clin Practice (as Associate Editor from 2015)
  9. Blood Purification (since 2013)
  10. Nephrology (as Subject Editor since 2009)
  11. J Diabetes (since 2008)
  12. J Nephrol & Renal Transplantation (since 2008)
  13. World J Hypertens (since 2012)
  14. World J Nephrol (2012)
  15. J Geriatric Cardiology (since 2014)
  16. Austin Biomarkers and Diagnosis (since 2014)
  17. Biomedicine Hub (Since 2016)
  18. European Medical Journal – Nephrology (Since 2017 as Editor-In-Chief since July 2018)
  19. Renal Replacement Therapy – Official Journal of Japanese Society of Dialysis and Transplantation (as Associate Editor since 2018)